Periodic assessment of (ET-1) and Nitric Oxide(NO) in hypertensive disorders of pregnancy (HDP)

Hypertensive Disorders of Pregnancy (HDP) is an independent risk factors of cardiovascular (CVS) disease. The prevalence of Hypertensive Disorders of Pregnancy (HDP) in Malaysia is approximately 23.3 per 1000 live births Endothelin-1 (ET-1), a potent vasoconstriction, has been identified as a piv...

Full description

Bibliographic Details
Main Authors: Ismawi, Hidayatul Radziah, Abdul Razak, Tariq, Jamani, Nurjasmine Aida, Mohd Zainudin, Maizura
Format: Proceeding Paper
Language:English
English
Published: 2019
Subjects:
Online Access:http://irep.iium.edu.my/71528/
http://irep.iium.edu.my/71528/12/FAOPS%202019%20FINAL%20EDITED%20poster%20pdf.pdf
http://irep.iium.edu.my/71528/23/71528_Periodic%20assessment%20of%20%28ET-1%29.pdf
_version_ 1848787465320529920
author Ismawi, Hidayatul Radziah
Abdul Razak, Tariq
Jamani, Nurjasmine Aida
Mohd Zainudin, Maizura
author_facet Ismawi, Hidayatul Radziah
Abdul Razak, Tariq
Jamani, Nurjasmine Aida
Mohd Zainudin, Maizura
author_sort Ismawi, Hidayatul Radziah
building IIUM Repository
collection Online Access
description Hypertensive Disorders of Pregnancy (HDP) is an independent risk factors of cardiovascular (CVS) disease. The prevalence of Hypertensive Disorders of Pregnancy (HDP) in Malaysia is approximately 23.3 per 1000 live births Endothelin-1 (ET-1), a potent vasoconstriction, has been identified as a pivotal mediator in HDP. Disturbances in nitric oxide (NO) bioavailability found in endothelial dysfunction may increase susceptibility to cardiovascular disease such as hypertension. HDP is defined as systolic blood pressure >= 140 mmHg and/or diastolic blood pressure >= 90 mmHg during pregnancy. HDP : gestational hypertension (GH), chronic hypertension (CH), pre-eclampsia (PE), and GH/CH superimposed with PE. (GH is diagnosed at >= 20 weeks and resolves <= 12 weeks postpartum. PE: proteinuria component and CH includes women already previously diagnosed with essential hypertension prior to the pregnancy.
first_indexed 2025-11-14T17:25:22Z
format Proceeding Paper
id iium-71528
institution International Islamic University Malaysia
institution_category Local University
language English
English
last_indexed 2025-11-14T17:25:22Z
publishDate 2019
recordtype eprints
repository_type Digital Repository
spelling iium-715282019-04-12T04:03:33Z http://irep.iium.edu.my/71528/ Periodic assessment of (ET-1) and Nitric Oxide(NO) in hypertensive disorders of pregnancy (HDP) Ismawi, Hidayatul Radziah Abdul Razak, Tariq Jamani, Nurjasmine Aida Mohd Zainudin, Maizura R Medicine (General) RA Public aspects of medicine RG Gynecology and obstetrics RG551 Pregnancy Hypertensive Disorders of Pregnancy (HDP) is an independent risk factors of cardiovascular (CVS) disease. The prevalence of Hypertensive Disorders of Pregnancy (HDP) in Malaysia is approximately 23.3 per 1000 live births Endothelin-1 (ET-1), a potent vasoconstriction, has been identified as a pivotal mediator in HDP. Disturbances in nitric oxide (NO) bioavailability found in endothelial dysfunction may increase susceptibility to cardiovascular disease such as hypertension. HDP is defined as systolic blood pressure >= 140 mmHg and/or diastolic blood pressure >= 90 mmHg during pregnancy. HDP : gestational hypertension (GH), chronic hypertension (CH), pre-eclampsia (PE), and GH/CH superimposed with PE. (GH is diagnosed at >= 20 weeks and resolves <= 12 weeks postpartum. PE: proteinuria component and CH includes women already previously diagnosed with essential hypertension prior to the pregnancy. 2019-03-29 Proceeding Paper NonPeerReviewed application/pdf en http://irep.iium.edu.my/71528/12/FAOPS%202019%20FINAL%20EDITED%20poster%20pdf.pdf application/pdf en http://irep.iium.edu.my/71528/23/71528_Periodic%20assessment%20of%20%28ET-1%29.pdf Ismawi, Hidayatul Radziah and Abdul Razak, Tariq and Jamani, Nurjasmine Aida and Mohd Zainudin, Maizura (2019) Periodic assessment of (ET-1) and Nitric Oxide(NO) in hypertensive disorders of pregnancy (HDP). In: 9th Federation of the Asian and Oceania Physiological Societies (FAOPS) Congress 2019, 28th-31st March 2019, Kobe, Japan. (Unpublished) http://www.nips.ac.jp/hsdev/FAOPS_2019/index_org.html
spellingShingle R Medicine (General)
RA Public aspects of medicine
RG Gynecology and obstetrics
RG551 Pregnancy
Ismawi, Hidayatul Radziah
Abdul Razak, Tariq
Jamani, Nurjasmine Aida
Mohd Zainudin, Maizura
Periodic assessment of (ET-1) and Nitric Oxide(NO) in hypertensive disorders of pregnancy (HDP)
title Periodic assessment of (ET-1) and Nitric Oxide(NO) in hypertensive disorders of pregnancy (HDP)
title_full Periodic assessment of (ET-1) and Nitric Oxide(NO) in hypertensive disorders of pregnancy (HDP)
title_fullStr Periodic assessment of (ET-1) and Nitric Oxide(NO) in hypertensive disorders of pregnancy (HDP)
title_full_unstemmed Periodic assessment of (ET-1) and Nitric Oxide(NO) in hypertensive disorders of pregnancy (HDP)
title_short Periodic assessment of (ET-1) and Nitric Oxide(NO) in hypertensive disorders of pregnancy (HDP)
title_sort periodic assessment of (et-1) and nitric oxide(no) in hypertensive disorders of pregnancy (hdp)
topic R Medicine (General)
RA Public aspects of medicine
RG Gynecology and obstetrics
RG551 Pregnancy
url http://irep.iium.edu.my/71528/
http://irep.iium.edu.my/71528/
http://irep.iium.edu.my/71528/12/FAOPS%202019%20FINAL%20EDITED%20poster%20pdf.pdf
http://irep.iium.edu.my/71528/23/71528_Periodic%20assessment%20of%20%28ET-1%29.pdf